| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 09.05.
| Small Biotechs Like Aastrom Biosciences and Geron Likely to Benefit From New Patent System / Five Star Equities Provides Stock Research on Aastrom Biosciences and Geron | | 53 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/09/12 -- In recent months the Biotech Industry has become a hotbed of Merger and Acquisition (M&A) activity and speculation. As large pharmaceuticals face major...
Mehr lesen zu:
Small Biotechs Like Aastrom Biosciences and Geron Likely to Benefit From New Patent System / Five Star Equities Provides Stock Research on Aastrom Biosciences and Geron | |
| 07.05.
| GERON CORP - 10-Q, Quarterly Report | | 8 | SEC Filings |
| 03.05.
| Geron Narrows Loss on Lower Costs | | 6 | Zacks |
| 02.05.
| Geron Down 6.1%, Shares Slide into the Red | | 4 | SmarTrend |
| 20.04.
| Traders Get Bullish on Shares of Geron, Shares Up 5.7% | | 8 | SmarTrend |
| 10.04.
| Hot Stock: Geron, Shares Gain 5.3% | | 7 | SmarTrend |
| 10.04.
| Biotech Stocks Look to Benefit From JOBS Act / Five Star Equities Provides Stock Research on Geron Corporation and Athersys, Inc. | | 55 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 04/10/12 -- One major problems in recent years for emerging biotech companies has been funding for research. With the signing of the Jumpstart Our Business Startups...
Mehr lesen zu:
Biotech Stocks Look to Benefit From JOBS Act / Five Star Equities Provides Stock Research on Geron Corporation and Athersys, Inc. | |
| 27.03.
| GERON CORP - 10-K/A, Annual Report | | 7 | SEC Filings |
| 27.02.
| Breakthrough Cancer Treatments Helping Death Rates Fall / The Paragon Report Provides Equity Research on Geron Corporation & Onyx Pharmaceuticals | | 36 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 02/27/12 -- Advances in cancer screening and treatment has caused the death rate from cancer to drop dramatically in recent years. Cancer death rates dropped by 1.8...
Mehr lesen zu:
Breakthrough Cancer Treatments Helping Death Rates Fall / The Paragon Report Provides Equity Research on Geron Corporation & Onyx Pharmaceuticals | |
| 12.12.
| Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer | | 35 | Business Wire |
| Geron Corporation (Nasdaq:GERN) today announced the initiation of
GRABM-B (GRN1005 Against Brain Metastases – Breast
cancer), a Phase 2 clinical trial to evaluate GRN1005...
Mehr lesen zu:
Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer | |
